HOSPIRA INC, LAKE FOREST recalls Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral M
Recalled August 16, 2017 · FDA recall D-1080-2017 · HOSPIRA INC, LAKE FOREST
Hazard
Presence of Particulate Matter: Silicone oil · FDA Class II
Units
14,300 vials
Sold at
Nationwide in the USA
Description
Presence of Particulate Matter: Silicone oil
Product
Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. NDC: 0703-0018-01
Manufacturer(s)
HOSPIRA INC, LAKE FOREST
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →